Evaluation of Autologous Natural Killer Cell Activity in Primary Cancer Cell Cultures

NCT05869994 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-07-05

No results posted yet for this study

Summary

The objectives of the study is to evaluate the anti-tumor activity of autologous natural killer cells in cultures of cancer cells obtained from patient's own tumor.

Conditions

  • Sarcoma

Sponsors & Collaborators

  • Sarcoma Oncology Research Center, LLC

    lead OTHER

Principal Investigators

  • Erlinda M Gordon, MD · Sarcoma Oncology Research Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-27
Primary Completion
2024-07-01
Completion
2024-07-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05869994 on ClinicalTrials.gov